Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes
Marc Pfefferlé, … , Dominik J. Schaer, Florence Vallelian
Marc Pfefferlé, … , Dominik J. Schaer, Florence Vallelian
Published July 14, 2020
Citation Information: J Clin Invest. 2020;130(10):5576-5590. https://doi.org/10.1172/JCI137282.
View: Text | PDF
Research Article Hematology

Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes

  • Text
  • PDF
Abstract

During hemolysis, macrophages in the liver phagocytose damaged erythrocytes to prevent the toxic effects of cell-free hemoglobin and heme. It remains unclear how this homeostatic process modulates phagocyte functions in inflammatory diseases. Using a genetic mouse model of spherocytosis and single-cell RNA sequencing, we found that erythrophagocytosis skewed liver macrophages into an antiinflammatory phenotype that we defined as MarcohiHmoxhiMHC class IIlo erythrophagocytes. This phenotype transformation profoundly mitigated disease expression in a model of an anti-CD40–induced hyperinflammatory syndrome with necrotic hepatitis and in a nonalcoholic steatohepatitis model, representing 2 macrophage-driven sterile inflammatory diseases. We reproduced the antiinflammatory erythrophagocyte transformation in vitro by heme exposure of mouse and human macrophages, yielding a distinctive transcriptional signature that segregated heme-polarized from M1- and M2-polarized cells. Mapping transposase-accessible chromatin in single cells by sequencing defined the transcription factor NFE2L2/NRF2 as a critical driver of erythrophagocytes, and Nfe2l2/Nrf2 deficiency restored heme-suppressed inflammation. Our findings point to a pathway that regulates macrophage functions to link erythrocyte homeostasis with innate immunity.

Authors

Marc Pfefferlé, Giada Ingoglia, Christian A. Schaer, Ayla Yalamanoglu, Raphael Buzzi, Irina L. Dubach, Ge Tan, Emilio Y. López-Cano, Nadja Schulthess, Kerstin Hansen, Rok Humar, Dominik J. Schaer, Florence Vallelian

×

Figure 7

Tolerance against diet-induced nonalcoholic fatty liver disease in hemolytic mice.

Options: View larger image (or click on image) Download as PowerPoint
Tolerance against diet-induced nonalcoholic fatty liver disease in hemol...
(A) Scans of H&E-stained liver lobe sections at ×15 magnification (left) or ×200 magnification (right) from Sptawt/wt (blue) and Sptasph/sph (red) mice fed a methionine- and choline-deficient (MCD) or control diet for 12 days. The images displayed are representative of 5 animals in each group. (B) Sptawt/wt (blue) and Sptasph/sph (red) mice that were fed an MCD or control diet for 12 days. Top to bottom: mRNA expression of Tnf in F4/80+ liver macrophages measured by RT-qPCR (n = 3–7), plasma ALT (n = 8–23), and CCL2 (n = 3–5) concentrations. (C) Quantitative morphometric analysis of the area with macrosteatosis in liver tissues (percentage of the total tissue area) based on liver histology images of the 5 mice mentioned in A (n = 2–5). (D) Microphotographs of liver tissues from MCD diet–fed Sptawt/wt and Sptasph/sph mice stained for F4/80+ macrophages. Scale bar: 100 μm. (E) Plasma ALT concentrations from Sptawt/wt mice treated with dimethyl fumarate (DMF) at 100 mg/kg (or vehicle control) for 7 days and then fed control or MCD diet for 12 days (n = 3–6). Individual symbols represent 1 mouse. ***P < 0.001; **P < 0.01; *P < 0.05 by ANOVA with Tukey’s post hoc test for all panels.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts